The Close: S&P 500 Stumbles as Moderna Sinks on Report Questioning Trial Results

2020-06-19T19:11:07+00:00May 19th, 2020|

Major averages fell to session lows in the wake of a report from STAT News that questioned the validity of the results of Moderna’s vaccine trial, which the company had announced Monday. Moderna shares plunged about 10% after the report.